24小时热门版块排行榜

>论坛更新日志 (4320)
>文献求助 (323)
>虫友互识 (251)
>基金申请 (228)
>导师招生 (189)
>休闲灌水 (137)
>硕博家园 (136)
>论文投稿 (126)
>考博 (90)
>教师之家 (89)
>考研 (77)
>博后之家 (66)
>论文道贺祈福 (55)
>找工作 (49)
>公派出国 (44)
>绿色求助(高悬赏) (40)

返回列表

【奖励】本帖被评价6次，作者尘3687增加金币 4.8 个

尘3687

铁杆木虫 (著名写手)

应助: 0 (幼儿园)
金币: 7950.8
帖子: 1342
在线: 59.8小时
虫号: 17600342

[资源] Polymorphism in the Pharmaceutical Industry （2018）

Polymorphism in the Pharmaceutical Industry: Solid Form and Drug Development（制药行业中的多态性：固体形式和药物开发 2018版）

About this book
"Polymorphism in the Pharmaceutical Industry - Solid Form and Drug Development" highlights the relevance of polymorphism in modern pharmaceutical chemistry, with a focus on quality by design (QbD) concepts. It covers all important issues by way of case studies, ranging from properties and crystallization, via thermodynamics, analytics and theoretical modelling right up to patent issues.
As such, the book underscores the importance of solid-state chemistry within chemical and pharmaceutical development. It emphasizes why solid-state issues are important, the approaches needed to avoid problems and the opportunities offered by solid-state properties. The authors include true polymorphs as well as solvates and hydrates, while providing information on physicochemical properties, crystallization thermodynamics, quantum-mechanical modelling, and up-scaling. Important analytical tools to characterize solid-state forms and to quantify mixtures are summarized, and case studies on solid-state development processes in industry are also provided.
Written by acknowledged experts in the field, this is a high-quality reference for researchers, project managers and quality assurance managers in pharmaceutical, agrochemical and fine chemical companies as well as for academics and newcomers to organic solid-state chemistry.

目录

CHAPTER 1 Solid State and Polymorphism of the Drug Substance in the Context of Quality by Design and ICH Guidelines Q8–Q12 (Pages: 1-30)

CHAPTER 2 Alternative Solid Forms: Salts (Pages: 31-59)

CHAPTER 3 Alternative Solid Forms: Co‐crystals (Pages: 61-90)

CHAPTER 4 Thermodynamics of Polymorphs and Solvates (Pages: 91-132)

CHAPTER 5 Toward Computational Polymorph Prediction (Pages: 133-157)

CHAPTER 6 Hygroscopicity and Hydrates in Pharmaceutical Solids (Pages: 159-188)

CHAPTER 7 The Amorphous State (Pages: 189-239)

CHAPTER 8 Approaches to Solid‐Form Screening (Pages: 241-259)

CHAPTER 9 Nucleation (Pages: 261-283)

CHAPTER 10 Crystallization Process Modeling (Pages: 285-304)

CHAPTER 11 Crystallization Process Scale‐Up, a Quality by Design (QbD) Perspective (Pages: 305-328)

CHAPTER 12 Processing‐Induced Phase Transformations and Their Implications on Pharmaceutical Product Quality (Pages: 329-380)

CHAPTER 13 Surface and Mechanical Properties of Molecular Crystals (Pages: 381-414)

CHAPTER 14 Analytical Tools to Characterize Solid Forms (Pages: 415-446)

CHAPTER 15 Industry Case Studies (Pages: 447-468)

CHAPTER 16 Pharmaceutical Crystal Forms and Crystal‐Form Patents: Novelty and Obviousness

回复此楼

» 本帖附件资源列表

欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com
附件 1 : polymorphism-in-the-pharmaceutical-industry-2018.pdf

2020-01-08 14:09:42, 14.08 M